Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
Bioorganic Chemistry|June 26, 2026
Benzothiazole-based molecular rotor as near-infrared (NIR) fluorescent probes for viscosity sensingWisaruta Junjai, Sorawis Sangtawesin, Sirimongkon Aryamueang, et al.
Future Science OA|March 9, 2026
Glucosamine induces apoptosis of cholangiocarcinoma cells by suppressing high-mannose type N-glycosylation and EGFR/STAT3 signalingOrawan Waenphimai, Cheerapinya Taebprakhon, Chatchai Phoomak, et al.
Journal of Clinical Medicine|May 25, 2024
Advancing Age May Decrease Mitochondrial Activity in Cumulus CellsSuwichaya Jitngamsujarit, Lingling Salang, Charupong Saengboonmee, et al.
Exploration of Targeted Anti-Tumor Therapy|May 15, 2024
Magnetite nanoparticles: an emerging adjunctive tool for the improvement of cancer immunotherapyPhoomipat Jungcharoen, Kunakorn Thivakorakot, Nachayada Thientanukij, et al.
Archives of Medical Research|January 31, 2026
Pro-Tumorigenic Roles of Cyclin Dependent Kinase 2 and its Associated Cyclins in Cholangiocarcinoma Progression under High Glucose ConditionCheerapinya Taebprakhon, Supannika Sorin, Kullanat Khawkhiaw, et al.
Cancer Treatment and Research Communications|June 29, 2026
Association of glucagon-like peptide 1 receptor and the aggressiveness of extrahepatic cholangiocarcinomaYongyot Varathorn, Mathawee Chanamarnjuntho, Ronnakrit Trakoonsenathong, et al.
Glycobiology|December 26, 2025
High glucose enhances lung cancer cell aggressiveness: The impacts of GLUT1, UAP1, UGP2, and N-linked GlycosylationChatchai Phoomak, Charupong Saengboonmee, Marta Baro, et al.
Anticancer Research|December 3, 2024
Targeting EGFR Activation to Overcome Gemcitabine Resistance in CholangiocarcinomaSonexai Kidoikhammouan, Worachart Lert-Itthiporn, Raksawan Deenonpoe, et al.
Natural Product Research|November 21, 2025
Chemical constituents from the roots of Morinda talmyi (Rubiaceae)Phornnapa Saentao, Florian T Schevenels, Wasan Seemakram, et al.
Life Sciences|January 29, 2021
High glucose upregulates FOXM1 expression via EGFR/STAT3 dependent activation to promote progression of cholangiocarcinomaMarutpong Detarya, Salak Thaenkaew, Wunchana Seubwai, et al.
Pageof 6